AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 122.02 billion Danish Kroner [US$17.92 billion]
of which 84%
was Diabetes and obesity),
Lonza Group AG
(5.92 billion Swiss Francs [US$6.13 billion]
based in GERMANY
(16.15 billion Euros [US$17.71 billion]
of which 42%
was Life Science).
During the year ended December of 2019, sales at
AstraZeneca PLC were £19.06 billion (US$23.59 billion).
increase of 14.8%
versus 2018, when the company's sales were £16.60 billion.